North Dakota State Investment Board
IONS icon

North Dakota State Investment Board’s Ionis Pharmaceuticals IONS Stock Holding History

North Dakota State Investment Board’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$373K Buy
4,703
+80
+2% +$6.02K 0.02% 594
2026
Q1 		$347K Sell
4,623
-857
-16% -$67.6K 0.02% 576
2025
Q4 		$434K Buy
+5,480
New +$413K 0.02% 564

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

North Dakota State Investment Board's IONS Position: Q2 2026 in Review

North Dakota State Investment Board increased its Ionis Pharmaceuticals (IONS) stake by 1.7% in Q2 2026, buying an estimated $6.02K and bringing the position to 4,703 shares worth $373K. The position accounts for 0.02% of the portfolio, ranked #594.

North Dakota State Investment Board first reported a position in IONS in Q4 2025 and has held it in 3 quarters since. The position peaked at $434K in Q4 2025. 516 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • North Dakota State Investment Board held 4,703 shares of Ionis Pharmaceuticals worth $373K as of Q2 2026.
  • North Dakota State Investment Board bought 80 Ionis Pharmaceuticals shares in Q2 2026, an estimated $6.02K.
  • Ionis Pharmaceuticals made up 0.02% of North Dakota State Investment Board's portfolio in Q2 2026, its #594 holding.
  • North Dakota State Investment Board first reported a position in Ionis Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • North Dakota State Investment Board's Ionis Pharmaceuticals position peaked at $434K in Q4 2025.
  • 516 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on North Dakota State Investment Board's 13F filing for Q2 2026, filed 4 Aug 2026.